Biotech: Pressemitteilungen - Kategorie - Seite 209

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Critical Outcome Technologies Inc. Completes Financing

LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 04/10/12 -- Critical Outcome Technologies Inc. (TSX VENTURE: COT) ("COTI" or the "Corporation") is pleased to announce the completion today of ...

Stem Cell Therapeutics Corp. Provides Corporate Update

CALGARY, ALBERTA: CALGARY, ALBERTA -- (Marketwire) -- 04/10/12 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS) ("SCT" or the "Company") has provided a corporate update for its shareholders now ...

Corcept Therapeutics Announces National Product Launch of Korlym(TM) for Patients With Endogenous Cushing's Syndrome

MENLO PARK, CA: MENLO PARK, CA -- (Marketwire) -- 04/10/12 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) announced today that Korlym™ (mifepristone) 300 mg Tablets is available by prescription nationwide.On ...

Nimble Approach to Partnerships Will Generate Value for Both CROs and the Pharmaceutical Industry, According to New Study

DUBLIN, IRELAND and NEW YORK, NY: DUBLIN, IRELAND and NEW YORK, NY -- (Marketwire) -- 04/10/12 -- As more and more R&D is outsourced by pharmaceutical companies, a study released today provides new insight into how to structure t ...

Boston Therapeutics PAZ320 Interim Clinical Trial Safety Results

MANCHESTER, NH: PAZ320 Tested at Dartmouth-Hitchcock Medical Center in New Hampshire ...

UPDATE: Data Published in Premier Endocrinology Journal Shows Korlym(TM) Provides Significant Clinical Improvement in Patients With Endogenous Cushing's Syndrome

MENLO PARK, CA: MENLO PARK, CA -- (Marketwire) -- 04/09/12 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharamceutical company engaged in the discovery, development and commercialization of drugs for the ...

Exclusive Video Q&A With Timothy M. Mayleben, CEO of Aastrom Biosciences

LOS ANGELES, CA: LOS ANGELES, CA -- (Marketwire) -- 04/09/12 -- Last month, Aastrom Biosciences, Inc. (NASDAQ: ASTM) announced that it had completed an impressive, $40 million private placement financing. The develo ...

Data Published in Premier Endocrinology Journal Shows Korlym(TM) Provides Significant Clinical Improvement in Patients With Endogenous Cushing's Syndrome

MENLO PARK, CA: MENLO PARK, CA -- (Marketwire) -- 04/09/12 -- The results of Corcept Therapeutics Incorporated's phase 3 SEISMIC trial published in The Journal of Clinical Endocrinology and Metabolism (JCEM) d ...

Functional Technologies Reports Management Change

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 04/05/12 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") reported that Mr. Kito Tosetti has departed from the Company, ef ...

Warnex Reports Year End 2011 Results

LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwire) -- 04/05/12 -- Warnex Inc. (TSX: WNX) ("Warnex") announced today financial results for the year ended December 31, 2011.2011 HighlightsFinancial ResultsConsol ...

Jacqueline Lemke Named CFO of BASi

WEST LAFAYETTE, IN: WEST LAFAYETTE, IN -- (Marketwire) -- 04/05/12 -- BASi (Bioanalytical Systems, Inc.) (NASDAQ: BASI) announced today that Jacqueline M. Lemke will join the company as Chief Financial Officer (CFO) an ...

Omni Bio to Hold Investor Conference Call on April 17

DENVER, CO: DENVER, CO -- (Marketwire) -- 04/05/12 -- (OTCBB: OMBP), a biopharmaceutical company, today announced that the Company will host a shareholder and investor conference call beginning at 2:30 p.m. MDT ...

Aptalis Pharma Inc. Commences Tender Offer for Its 12 3/4% Senior Notes Due 2016 and Solicitation of Consents

BRIDGEWATER, NJ: BRIDGEWATER, NJ -- (Marketwire) -- 04/05/12 -- (the "Company") today announced that it has commenced a cash tender offer for any and all of its outstanding 12 3/4% Senior Notes due 2016 (C ...

Warnex Provides an Update on its Operations

LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwire) -- 04/04/12 -- Warnex Inc. (TSX: WNX) ("Warnex") wishes to provide the following update regarding its operations.Financial SituationWarnex announces that it h ...

New Patent for Cartilage Repair Issues Under Vet-Stem Stem Cell License

POWAY, CA: POWAY, CA -- (Marketwire) -- 04/04/12 -- Vet-Stem, Inc. announced that another patent has issued under its exclusive worldwide license with Artecel, Inc. This patent covers using adipose tissue-deri ...

Open-Source Drug Research Consortium Draws a Major New Champion

TORONTO, CANADA, and OSAKA, JAPAN: - Six World Leading Drug Makers Contribute $50 Million for Early-Stage Research - New Approach Speeds Drug Development by Sharing Risks ...

Functional Technologies Signs LOI to Divest Non-Core Assets, Cut Non-Essential Spending

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 04/04/12 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") announced it has signed a Letter of Intent ("LOI") to ...

Promising Clinical Data in Breast and Liver Cancers Further Expand the Broad Therapeutic Potential of Peregrine's Bavituximab

TUSTIN, CA: Additional Preclinical Prostate Cancer Data Indicates Potent Immune Stimulation by PS-Targeting Antibodies Resulting in a 40% Cure Rate ...

Precision BioSciences Files Ninth Patent Infringement Lawsuit Against Cellectis Related to Engineered Meganucleases

RESEARCH TRIANGLE PARK, NC: RESEARCH TRIANGLE PARK, NC -- (Marketwire) -- 04/04/12 -- Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that it has filed a patent infringement lawsuit aga ...


Seite 209 von 255:  « ..  208 209 210  211  212  213  214  215  216  217  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z